Not found

Edward A. Graviss, PhD, MPH

Associate Professor of Pathology and Genomic Medicine, Institute for Academic Medicine
Associate Member, Research Institute
Houston Methodist

Research Lab

After receiving his doctoral degree in Epidemiology from The University of Texas Health Science Center at Houston, School of Public Health in 1993, Dr. Graviss joined the Michael DeBakey Houston VA Medical Center in Houston as an infectious disease epidemiologist, a position he still holds. He became a Research Instructor of Medicine at Baylor College of Medicine in 1994, and was later promoted to dual Associate Professorships there in the Departments of Pathology and Medicine in the section of Infectious Diseases, where he still holds adjunct positions. Dr. Graviss joined the Center for Molecular and Translational Human Infectious Diseases Research in the Houston Methodist Research Institute in 2008. Dr. Graviss holds several other joint adjunct positions including; Associate Professorships at the UT School of Public Health and the Division of the Health Sciences, the School of Biotechnology, and Health Tecnolóico de Monterrey, Monterrey, Mexico.


Description of Research

Dr. Graviss has extensive expertise in the study of the epidemiology and population-based surveillance of a variety of infectious agents including Mycobacterium tuberculosis. His recent studies focus on evaluation of the new Interferon Gamma Release Assays (IGRAs) in the diagnosis of latent tuberculosis infection.

Areas Of Expertise

Infectious agents Mycobacterium tuberculosis Latent tuberculosis
Education & Training

PhD, University of Texas Health Science Center
MPH, The University of Texas Health Science Center
MS, University of Texas San Antonio
BS, Texas Tech. University

Risk factors for extrapulmonary dissemination of tuberculosis and associated mortality during treatment for extrapulmonary tuberculosis article
Qian, X, Nguyen, DT, Lyu, J, Albers, AE, Bi, X & Graviss, EA 2018, Emerging Microbes and Infections, vol 7, no. 1, 102. DOI: 10.1038/s41426-018-0106-1

Chlorhexidine bathing and Clostridium difficile infection in a surgical intensive care unit
Bui, LN, Swan, JT, Shirkey, BA, Olsen, RJ, Long, SW & Graviss, EA 2018, The Journal of surgical research, vol 228, pp. 107-111. DOI: 10.1016/j.jss.2018.02.063

Schistosomiasis Induces Persistent DNA Methylation and Tuberculosis-Specific Immune Changes
DiNardo, AR, Nishiguchi, T, Mace, EM, Rajapakshe, K, Mtetwa, G, Kay, A, Maphalala, G, Secor, WE, Mejia, R, Orange, JS, Coarfa, C, Bhalla, KN, Graviss, EA, Mandalakas, AM & Makedonas, G 2018, Journal of Immunology, vol 201, no. 1, pp. 124-133. DOI: 10.4049/jimmunol.1800101

Ciprofloxacin for BK Viremia Prophylaxis in Kidney Transplant Recipients: Results of a Prospective, Randomized Controlled Trial
Patel, SJ, Nguyen, DTM, Graviss, EA, Nolte, JV, Agboli, I, Moore, LW, Kuten, SA, Pham, C, Gaber, AO & Knight, RJ 2018, 2018 American Transplant Congress (ATC), Seattle, United States, 6/2/18 - 6/6/18, .

Prevalence of Metabolic Syndrome (MetS) and Insulin Resistance in Living Kidney Donors
Agboli, I, Moore, LW, Nguyen, DTM, Graviss, EA, Ibrahim, H, Gaber, AO & Sadhu, A 2018, 2018 American Transplant Congress (ATC), Seattle, United States, 6/2/18 - 6/6/18, .

Computed tomography criteria for the use of advanced localization techniques in minimally invasive thoracoscopic lung resection
Kim, MP, Nguyen, DT, Chan, EY, Meisenbach, LM, Kopas, LM, Graviss, EA, Lumsden, AB & Gupta, N 2018, Journal of Thoracic Disease, vol 10, no. 6.

Yield in Electromagnetic Navigational Bronchoscopy (ENB) for Peripheral Pulmonary Nodules
Mudassar, A, Santacruz, JF, Nguyen, DTM & Graviss, EA 2018, ATS 2018 International Conference, Sandiego, United States, 5/18/18 - 5/23/18, .

Clinical evaluation of a blood assay to diagnose paucibacillary tuberculosis via bacterial antigens
Liu, C, Lyon, CJ, Bu, Y, Deng, Z, Walters, E, Li, Y, Zhang, L, Hesseling, AC, Graviss, EA & Hu, Y 2018, Clinical Chemistry, vol 64, no. 5, pp. 791-800. DOI: 10.1373/clinchem.2017.273698

Diagnostic and Treatment Monitoring Potential of A Stool-Based Quantitative Polymerase Chain Reaction Assay for Pulmonary Tuberculosis
DiNardo, AR, Kay, AW, Maphalala, G, Harris, NM, Fung, C, Mtetwa, G, Ustero, P, Dlamini, S, Ha, N, Graviss, EA, Mejia, R & Mandalakas, AM 2018, American Journal of Tropical Medicine and Hygiene. DOI: 10.4269/ajtmh.18-0004

Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia
Knight, RJ, Graviss, EA, Nguyen, DT, Kuten, SA, Patel, SJ, Gaber, L & Gaber, AO 2018, Clinical Transplantation, pp. e13265. DOI: 10.1111/ctr.13265

Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients
Nguyen, DT, Jenkins, HE & Graviss, EA 2018, PLoS ONE, vol 13, no. 4, pp. e0196022. DOI: 10.1371/journal.pone.0196022

Development and validation of a prognostic score to predict tuberculosis mortality
Nguyen, DT & Graviss, EA 2018, Journal of Infection. DOI: 10.1016/j.jinf.2018.02.009

Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients
Nguyen, DT, Jenkins, HE & Graviss, EA 2018, PLoS ONE, vol 13, no. 4, e0196022. DOI: 10.1371/journal.pone.0196022

Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series
Lunsford, KE, Javle, M, Heyne, K, Shroff, RT, Abdel-Wahab, R, Gupta, N, Mobley, CM, Saharia, A, Victor, DW, Nguyen, DT, Graviss, EA, Kaseb, AO, McFadden, RS, Aloia, TA, Conrad, C, Li, XC, Monsour, HP, Gaber, AO, Vauthey, J-N, Ghobrial, RM & Methodist–MD Anderson Joint Cholangiocarcinoma Collaborative Committee (MMAJCCC) 2018, The lancet. Gastroenterology & hepatology. DOI: 10.1016/S2468-1253(18)30045-1

Influence of Seasonality and Circulating Cytokines on Serial QuantiFERON Discordances
Griffin, ML, Agarwal, S, Murphy, MZ, Teeter, LD & Graviss, EA 2018, Tuberculosis research and treatment, vol 2018, pp. 6731207. DOI: 10.1155/2018/6731207

Characteristics Associated with Negative Interferon-? Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013-2015
Nguyen, DTM, Teeter, LD, Graves, J & Graviss, EA 2018, Emerging infectious diseases, vol 24, no. 3, pp. 534-540. DOI: 10.3201/eid2403.171633

Long-Term Survival in Bilateral Lung Transplantation for Scleroderma-Related Lung Disease
Chan, EY, Goodarzi, A, Sinha, N, Nguyen, DT, Youssef, JG, Suarez, EE, Kaleekal, T, Graviss, EA, Bruckner, BA, MacGillivray, TE & Scheinin, SA 2018, Annals of Thoracic Surgery, vol 105, no. 3, pp. 893-900. DOI: 10.1016/j.athoracsur.2017.09.038

Characteristics associated with negative interferon-? release assay results in culture-confirmed tuberculosis patients, Texas, USA, 2013–2015
Nguyen, DT, Teeter, LD, Graves, J & Graviss, EA 2018, Emerging Infectious Diseases, vol 24, no. 3, pp. 534-540. DOI: 10.3201/eid2403.171633

Tuberculosis Mortality in the United States: Epidemiology and Prevention Opportunities
Beavers, SF, Pascopella, L, Davidow, AL, Mangan, JM, Hirsch-Moverman, YR, Golub, JE, Blumberg, HM, Webb, RM, Royce, RA, Buskin, SE, Leonard, MK, Weinfurter, PC, Belknap, RW, Hughes, SE, Warkentin, JV, Welbel, SF, Miller, TL, Kundipati, SR, Lauzardo, M, Barry, PM, Katz, DJ, Garrett, DO, Graviss, EA, Flood, JM & Tuberculosis Epidemiologic Studies Consortium 2018, Annals of the American Thoracic Society. DOI: 10.1513/AnnalsATS.201705-405OC

Trends of diabetes and associated mortality in tuberculosis patients in Texas, a large population-based analysis
Nguyen, DTM & Graviss, EA 2018, 5th Texas Tuberculosis Research Symposium, El Paso, United States, 2/9/18, .